Fresenius Medical Care said it is expanding its transitional care units in the U.S. this year. The company plans to open more than 100 new TCUs in 2020 to help people recently diagnosed with kidney failure to learn about the treatment options available, including home dialysis. TCUs are designed as a separate space within a […]
Fresenius Medical Care North America launches connected health platform
Fresenius (NYSE:FMS) recently announced that its Fresenius Medical Care North America (FMCNA) business has launched a connected health platform called TheHub. TheHub includes three integrated applications meant to enable people on dialysis, their care teams, and health providers to better collaborate. Fresenius officials see the system enhancing remote monitoring for people on home dialysis. The Trump administration […]
Fresenius Medical Care wins FDA breakthrough nod for clot-preventing dialysis device
Fresenius Medical Care North America (NYSE:FMS) said today that it won breakthrough device designation from the FDA for the new hemodialysis system it’s developing. Waltham, Mass.-based Fresenius said its Endexo antithrombogenic additive is being incorporated into the manufacturing of dialyzers and bloodlines. The device is a polymer made of modifying molecules designed to inhibit the adsorption […]
Report: Fresenius to shutter Ohio billing operation, lay off 57
Fresenius Management Services (NYSE:FMS; ETR:FRE) is reportedly closing its medical billing facility and laying off nearly 60 employees in North Olmsted, Ohio. The company filed a Worker Adjustment and Retraining Notification on Oct. 4 saying that it would lay off 56 employees on December 6 and add one more employee to the layoffs on Jan. […]
Fresenius settles Medicare over-billing case for $5m
Fresenius Medical Care (NYSE:FMS; ETR:FRE) agreed to pay more than $5 million to resolve allegations that its dialysis clinic business over-billed Medicare for hepatitis B tests. The country’s largest dialysis clinic operator, Fresenius Medical Care North America agreed to pay $5.2 million to settle federal prosecutors’ allegations that it billed Medicare for tests of dialysis patients […]
Fresenius recalls dialysis tubes due to dangerous, undetectable leaks
Fresenius Medical Care (NYSE:FMS; ETR:FRE) last week recalled two sets of its bloodlines due to potentially deadly leaks in the tubes. Germany-based Fresenius said that two sets of its 4008 bloodlines (AV-Set B-R F00001124 and AV-Set SRB-R F00000257) containing a total of 25 batches experienced tube rupture that led to blood leakage. A dialysis machine cannot […]
Fresenius invests in BioIntelliSense
Fresenius Medical Care (NYSE:FMS; ETR:FRE) today announced an investment in BioIntelliSense for an undisclosed amount. Denver-based BioIntelliSense is developing a medical-grade data services platform for continuous remote health monitoring, predictive analytics and algorithmic clinical insights. Through the agreement, Fresenius will use the advanced analytics and artificial intelligence to develop medical wearables for clinical pathways that allow […]
Fresenius to expand kidney research
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said this week that it is expanding its clinical research activities. Frenova Renal Research, previously a Fresenius Medical Care North America subsidiary, will now offer its services worldwide and will be integrated into a new global medical office headed by chief medical officer Dr. Frank Maddux. Frenova offers services for […]
